The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Hydroxy-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline-2-carbonitrile ID: ALA4860699
PubChem CID: 164616494
Max Phase: Preclinical
Molecular Formula: C20H28N2O3
Molecular Weight: 344.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(cc1OC)C1CC(O)(C#N)C(CC(C)C)CN1CC2
Standard InChI: InChI=1S/C20H28N2O3/c1-13(2)7-15-11-22-6-5-14-8-18(24-3)19(25-4)9-16(14)17(22)10-20(15,23)12-21/h8-9,13,15,17,23H,5-7,10-11H2,1-4H3
Standard InChI Key: DGLPXLLFZLJOLW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
27.5691 -14.1158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1607 -13.4033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7479 -14.1132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3137 -10.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3125 -11.7349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0273 -12.1477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0255 -10.4949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7408 -10.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7396 -11.7369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1803 -10.9060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4588 -10.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1791 -11.7391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4532 -12.1490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4453 -12.9780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8875 -12.9935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8972 -12.1581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5975 -13.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3163 -13.0085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0263 -13.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3249 -12.1835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5977 -12.1468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8836 -11.7338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5992 -10.4953 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5990 -9.6703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9773 -14.8282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 11 1 0
9 13 1 0
12 10 1 0
10 11 1 0
12 13 1 0
12 16 1 0
13 14 1 0
14 2 1 0
2 15 1 0
15 16 1 0
15 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
5 21 1 0
21 22 1 0
4 23 1 0
23 24 1 0
1 25 3 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.46Molecular Weight (Monoisotopic): 344.2100AlogP: 2.92#Rotatable Bonds: 4Polar Surface Area: 65.72Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.93CX Basic pKa: 7.20CX LogP: 2.44CX LogD: 2.22Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.85Np Likeness Score: 0.72
References 1. Yang Y, Yu D, Zhu X, Du G, Wang W, Zou F, Wang H, Zhang R, Ye L, Tian J.. (2021) Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitors., 224 [PMID:34329999 ] [10.1016/j.ejmech.2021.113718 ]